Special Issue "Biodegradable Polymeric Implants for Drug Delivery and Cell Therapy Applications"
Deadline for manuscript submissions: closed (10 March 2023) | Viewed by 9754
Interests: biomaterials; biomimetic nanomaterials; drug delivery; tissue engineering; cell/therapeutic-material interaction; and 3d bioprinting
Interests: biomaterials; nanomedicine; immunotherapy; advanced drug delivery formulations; biomedical applications; drug delivery
Special Issues, Collections and Topics in MDPI journals
The use of biodegradable polymeric biomaterials for controlled drug delivery and cell therapy holds promise as a therapeutic option to improve treatment outcomes and patient compliance for various diseases. Hydrogels have become one of the most promising fields in drug/cell delivery systems due to their remarkable properties resembling living tissues and good biocompatibility with high tunability in physicochemical/biological properties. Many biodegradable hydrogel systems created by natural or synthetic polymers have been successfully developed to achieve therapeutic efficacy and minimize side effects while improving patient compliance. Moreover, various biofabrication technologies, such as microfluidics, 3D bioprinting, and electrospinning, have been applied in recent years to create hydrogels that can prolong the half-life of therapeutic cells from body clearance and avoid the immune recognition and emulate the natural cellular microenvironment for various cell therapy applications.
This Special Issue welcomes original research and review articles and aims to promote the recent advances in innovative biodegradable polymeric biomaterials for controlled drug/cell delivery. The potential topics include, but are not limited to, the following: 1) designing and developing implantable biodegradable polymeric biomaterials for drug/cell delivery utilizing various advanced polymer and/or nanoparticle technologies, such as stimuli-responsive synthetic and biopolymers; 2) manufacturing and processing biodegradable polymeric implants utilizing biofabrication technologies, such as microfluidics, 3D bioprinting and electrospinning for drug/cell delivery.
Dr. Panita Maturavongsadit
Dr. Narsimha Mamidi
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Polymers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- biodegradable biomaterials
- stimuli-responsive polymers
- smart materials
- in-situ forming implants
- long-acting delivery
- controlled drug delivery
- stem cell therapy
- tissue regeneration